Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PMS-RALOXIFENE DIN 02358921

Status: Cancelled Post Market
Holder: PHARMASCIENCE INC
Molecule: RALOXIFENE HYDROCHLORIDE

Health Canada record

Active ingredient(s)RALOXIFENE HYDROCHLORIDE 60 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCG03XC01 RALOXIFENE
Original market date19-Sep-2011
Current status date22-Apr-2020
SourceHealth Canada DPD

Establishment licence of the holder

Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RALOXIFENE HYDROCHLORIDE

DINProductCompanyFormStrengthStatus
02358840ACT RALOXIFENETEVA CANADA LIMITEDTabletRALOXIFENE HYDROCHLORIDE 60 MGMarketed
02279215APO-RALOXIFENEAPOTEX INCTabletRALOXIFENE HYDROCHLORIDE 60 MGMarketed
02540681JAMP RALOXIFENEJAMP PHARMA CORPORATIONTabletRALOXIFENE HYDROCHLORIDE 60 MGMarketed
02239028EVISTAELI LILLY CANADA INCTabletRALOXIFENE HYDROCHLORIDE 60 MGCancelled Post Market
02415852RALOXIFENEPRO DOC LIMITEETabletRALOXIFENE HYDROCHLORIDE 60 MGCancelled Post Market
02312298TEVA-RALOXIFENETEVA CANADA LIMITEDTabletRALOXIFENE HYDROCHLORIDE 60 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
118482010-11-04Abbreviated New Drug Submission (ANDS)

International API supply for RALOXIFENE HYDROCHLORIDE

10 valid EDQM Certificates of Suitability from 10 holders. 14 active FDA Drug Master Files.

Request a quote for PMS-RALOXIFENE

How to read a Canadian DIN record